Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ling-yan Yuan"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
The sustained benefit of immunotherapy-based regimens in epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) after EGFR-tyrosine kinase inhibitor (TKI) failure is debatable. Neither Checkmate-722 nor Keynote-789 reached
Externí odkaz:
https://doaj.org/article/01fa2f4d72644d12bacdd7c6eb71c1e0
Autor:
Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, Ke Liu, Ying Wu, Yan Ling, Wen-Xing Qin, Miao-Miao Wang, Ling-Yan Yuan, Savio George Barreto, Anthony W. Kim, Kimberley Mak, Hao Li, Yuan-Yuan Xu, Xiao-Ming Qiu, Min Wu, Min Jin, Li-Chao Xu, Yi Zhong, Hui Yang, Xue-Qin Chen, Yu Zeng, Jun Shi, Wen-Yu Zhu, Qing-Qing Ding, Wei Jia, Su-Fen Liu, Jun-Jing Zhou, Hong Shen, Shi-Hua Yao, Zhao-Ji Guo, Ting Li, Pei-Juan Zhou, Xue-Wei Dong, Wen-Feng Lu, Robert L. Coleman, Mehmet Akce, Chérif Akladios, Francesco Puccetti, Yuan-Sheng Zang
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
PurposeWe evaluated he effects of molecular guided-targeted therapy for intractable cancer. Also, the epidemiology of druggable gene alterations in Chinese population was investigated.Materials and methodsThe Long March Pathway (ClinicalTrials.gov id
Externí odkaz:
https://doaj.org/article/57373dea8a5b45d1b3cb59515c3222e3
Autor:
Zhan Wang, Yan Geng, Ling-Yan Yuan, Miao-Miao Wang, Chen-Yang Ye, Li Sun, Wei-Ping Dai, Yuan-Sheng Zang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal neoplasm and patients with IMT tend to have a favorable outcome after complete surgical resection. However, some tumors of IMT cases have recurred and grown rapidly after successful surge
Externí odkaz:
https://doaj.org/article/c8ef8fa35a20479ea3aed1c5f5b2d06e
Autor:
Shu-Guang Li, Qian-Wei Shi, Ling-yan Yuan, Li-ping Qin, Yan Wang, Yu-Qing Miao, Zhe Chen, Chang-Quan Ling, Wen-xing Qin
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-13 (2018)
Abstract Background Triptolide is a structurally unique diterpene triepoxide with potent antitumor activity. However,the effect and mechanism of triptolide on hepatocellular carcinoma (HCC) is not well studied. Methods Cells were treated with triptol
Externí odkaz:
https://doaj.org/article/149c9a20a0054e5f8a473408e7b8b03c
Autor:
Zhan Wang, Bao-Dong Qin, Chen-Yang Ye, Miao-Miao Wang, Ling-Yan Yuan, Wei-Ping Dai, Li Sun, Ke Liu, Wen-Xing Qin, Xiao-Dong Jiao, Xing-Nan Li, Yuan-Sheng Zang
Publikováno v:
European Journal of Cancer. 163:152-162
Current therapeutic regimens for patients with v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E-mutated colorectal cancer show unsatisfactory efficacy. To improve outcomes in this area, we assessed the safety and efficacy of a new protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033917c0c6c39ec22b6f1bf65b9efbbc
https://doi.org/10.1016/j.ejca.2021.12.028
https://doi.org/10.1016/j.ejca.2021.12.028
Mechanism of Fuzheng Kang’ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Publikováno v:
Chinese Journal of Integrative Medicine. 28:425-433
To study the mechanism of Chinese herbal medicine Fuzheng Kang’ai Formula (扶正抗癌方, FZKA) on tumor microenvironment (TME). CIBERSORTx was used for analysis of TME. Traditional Chinese Medicine Systems Pharmacology and Analysis Platform was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5d68287906fa0dbf157074c3378163c
https://doi.org/10.1007/s11655-021-3451-1
https://doi.org/10.1007/s11655-021-3451-1
Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
Publikováno v:
Chinese journal of integrative medicine. 28(5)
To study the mechanism of Chinese herbal medicine Fuzheng Kang'ai Formula (, FZKA) on tumor microenvironment (TME).CIBERSORTx was used for analysis of TME. Traditional Chinese Medicine Systems Pharmacology and Analysis Platform was applied to identif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0bd03d3049277b2e79500cc1678d6dd8
https://pubmed.ncbi.nlm.nih.gov/34546538
https://pubmed.ncbi.nlm.nih.gov/34546538
Autor:
Bao-Dong Qin, Wen-Xing Qin, Zhan Wang, Xiao-Dong Jiao, Ke Liu, Ling-Yan Yuan, Yuan-Sheng Zang
Publikováno v:
OncoTargets and therapy
In patients without tissue availability at presentation, the analysis of cell-free DNA derived from liquid biopsy samples, in particular from plasma, represents an established alternative for providing epidermal growth factor receptor (EGFR) mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d064fd64c138bb855a9ffd31c6b50df
https://doi.org/10.2147/ott.s167346
https://doi.org/10.2147/ott.s167346
Publikováno v:
Cancer Management and Research
Bao-Dong Qin,*Xiao-Dong Jiao,* Ling-Yan Yuan,Ke Liu,Yuan-Sheng Zang Department of Medical Oncology, Changzheng Hospital, Second Military Medical University, Shanghai, China *These authors contributed equally to this work Introduction: Adenosquamous c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07a9279a4e1fbd9d3cb6c5d68ce6c9bd
http://europepmc.org/articles/PMC5846297
http://europepmc.org/articles/PMC5846297
Nab-paclitaxel is a recently emerged chemotherapy drug, which is widely used for the treatment of multiple types of cancer. The prospects of this novel drug are very bright as a result of its higher efficacy and lower toxicity compared with paclitaxe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c73399be9cfd80b221d4fa99fed8e85a
https://europepmc.org/articles/PMC4840571/
https://europepmc.org/articles/PMC4840571/
